| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Goodman Daniel Wintner is a Director at Tonix Pharmaceuticals Holding Corp.. Recent SEC Form 4 filings include 1 buy and 0 sells.
Estimated insider holdings value: $69K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 25, 2021 | TNXP Tonix Pharmaceuticals Holding Corp. | Director | Buy | 5,000 | $1.12 | $5,600.00 | +500,000% | -38.4% | -94.4% |